Lisa Bero

Last updated

Lisa Anne Bero
Lisa Bero 22-Sept-2013.jpg
Lisa Bero at the 21st Annual Cochrane Colloquium, Quebec, September 2013
Born
Lisa Anne Bero

(1958-08-04) 4 August 1958 (age 64)
New Orleans, Louisiana
Alma mater
Known for
  • Research and policy on industry influence on research
  • Studying research integrity
  • WHO essential medicines
  • Cochrane Collaboration
  • The Cigarette Papers (1996)
Scientific career
Fields
  • Translating research into health policy
  • Research integrity
  • Essential medicines
Institutions
Thesis The interaction of opioid and serotonergic systems regulation prolactin secretion in the developing rat (1987)

Lisa Anne Bero, born 1958, is an academic who originally trained in pharmacology and went on to a career studying research integrity and how clinical and basic sciences are translated into clinical practice and health policy. [1] [2] She is Chair of Medicines Use and Health Outcomes at the University of Sydney. [3] From 1991 until 2014, she was Professor in the Department of Clinical Pharmacy (School of Pharmacy) and in the Institute of Health Policy Studies (School of Medicine) at the University of California, San Francisco (UCSF), and is currently an adjunct professor there. [4] She is also Chair of the World Health Organization (WHO) Essential Medicines Committee, [5] Director of the WHO Collaborating Centre for Pharmaceutical Research and Science Policy, [6] and Co-Chair of the Cochrane Collaboration. [7] Bero has received multiple awards for her extensive mentoring of high school students to junior faculty. [8]

Contents

Education

Bero gained a Bachelor of Science in physiology and philosophy from Michigan State University in 1980. [4] She was awarded a PhD in pharmacology and toxicology from Duke University in 1987. [9] She received a National Institute on Drug Abuse postdoctoral fellowship on the molecular basis of opiate addiction, but left basic research for health policy when she received a Pew Health Policy Fellowship in 1988, which included training in epidemiology. [1] [10]

Career

A fellowship from the Pew Charitable Trust enabled her to make a transition from the basic sciences to health policy. [10] Bero explained the impact of this on her career: "I do a lot of work on government committees and international committees. Had it not been for the Pew program I would have been a much more typical academic." [10] She had a particular interest in the evidence basis for health practice and policy, often in controversial areas. [1] She began researching both the evidence to improve prescribing, and the influence of the pharmaceutical industry on drug research, and going on to an interest in the tobacco industry's influence on research and policy. [1] Her areas of research have since also included methods for assessing bias and quality of research and scientific publications, and the dissemination and policy implications of research. [5]

Bero went on to advocate for policy changes at both policy and community levels, for example to end tobacco sales in San Francisco pharmacies. [11] She is a co-author of The Cigarette Papers, [12] a collection of documents published in 1996 that played a key role in litigation of tobacco companies. It has been called "the Pentagon Papers of tobacco." [13]

After her postdoctoral position, Bero joined the faculty of the University of California, San Francisco (UCSF) where she was Professor in the Department of Clinical Pharmacy (School of Pharmacy), Professor in the Institute of Health Policy Studies (School of Medicine), and Vice-Chair for Research in the Department of Clinical Pharmacy until 2014. [4] She served as Chair of the UCSF Chancellor's Advisory Committee on Conflicts of Interest. [5]

Bero was a member of the Institute of Medicine Committee on Conflict of Interest in Medical Research, Education and Practice, which published its report in 2009. [2] Along with Robert Krughoff and George Loewenstein, she co-authored a minority opinion entitled "Model for broader disclosure" (Appendix F) arguing that given the "serious limitations in the accuracy, completeness, comparability, and timeliness of conflict of interest information reported to institutions and to the public," the IOM recommendations did not go far enough. Their proposed model was based on the development of a database centralizing data on academics' potential conflicts of interest. [2]

She was a senior editor of the journal Tobacco Control, and an editor for the Cochrane Effective Practice and Organisation of Care Group in the Cochrane Database of Systematic Reviews. [14]

In 2014 Lisa was appointed the inaugural Chair of Medicines Use and Health Outcomes in the Faculty of Pharmacy and Charles Perkins Centre at the University of Sydney. [3] She runs two research programs (Research Integrity and Science Policy and Improving Medicines Use for Noncommunicable Diseases in Low Resource Settings) on bias and its influence on the integrity of research. Her work spans basic science through to translation into policy:

1. Research Integrity and Science Policy: Professor Bero develops and validates innovative methods for assessing the source and extent of bias in the design, conduct and dissemination of research in human trials and observational studies, as well as animal studies. Her research takes account of the cultural, social, corporate, political and other influences on the design, conduct and publication of research and has a particular focus on producing unbiased evidence and promoting evidence-based decision making in studies on the prevention and treatment of obesity, diabetes and cardiovascular disease.

2. Improving Medicines Use for Noncommunicable Diseases in Low Resource Settings: Professor Bero is studying the assess barriers and facilitators to improve medicines use for noncommunicable diseases in low resource settings. This includes developing and testing interventions to improve essential medicines policy, supply, distribution and use.

World Health Organization

Bero's first contact with the World Health Organization (WHO) occurred through her Pew Fellowship in the late 1980s. [10] She has been first an advisor, then a member of the WHO Essential Medicines Committee since 2005, and is currently Chair. [5] Bero has been a member of the Pan American Health Organization's (PAHO, WHO Regional Office for the Americas) Advisory Committee for Health Research (ACHR) since 2008. [15]

In 2011, she became the foundation Director of the WHO Collaborating Centre for Pharmaceutical Research and Science Policy. [6] The Centre's areas of work are pharmaceuticals (including essential medicines), health systems research and development, and research policy. [6]

In 2011, the Cochrane Collaboration became a non-governmental organization in official relations with the World Health Organization (WHO), including a seat on the World Health Assembly. [16] Bero is one of the Collaboration's two representatives for WHO. [16]

Cochrane Collaboration

Bero was an editor of the Cochrane Collaboration Review Group on Effective Professional Practice and Organization of Care from the late 1990s. [17] She led the development of the Criticism Management System for the Cochrane Library, implemented in 1997. [18]

Bero has been the Director of the San Francisco Branch of the United States Cochrane Center since its original establishment as the San Francisco Cochrane Center in 1995, at which time she served with co-director Drummond Rennie. [19] She is now Co-Director of the US Cochrane Center. [20] She served on the Collaboration Steering Group from 1996 to 2000, and again from 2004 to 2010. [21] Bero rejoined the Steering Group when she was elected Co-Chair of the Collaboration in 2013. [5]

Awards and honors

Related Research Articles

<span class="mw-page-title-main">University of California, San Francisco</span> Public university in San Francisco, California

The University of California, San Francisco (UCSF) is a public land-grant medical school in San Francisco, California. It is part of the University of California system and is dedicated entirely to health science and life science. It conducts research and teaching in medical and biological sciences.

Steven A. Schroeder is Distinguished Professor of Health and Health Care at the University of California, San Francisco (UCSF), where he also heads the Smoking Cessation Leadership Center. He served as the president and CEO of the Robert Wood Johnson Foundation from 1990 to 2002. Schroeder is known for his work in promoting smoking cessation strategies.

Haile Debas is an Eritrean physician and academic administrator at the University of California, San Francisco.

Stanton Arnold Glantz is an American professor, author, and tobacco control activist. Glantz is a faculty member at the University of California, San Francisco (UCSF) School of Medicine, where he is a Professor of Medicine (retired) in the Division of Cardiology, the American Legacy Foundation Distinguished Professor of Tobacco Control, and former director of the Center for Tobacco Control Research and Education. Glantz's research focused on the health effects of tobacco smoking.

The Drug Industry Documents Archive (DIDA) is a digital archive of pharmaceutical industry documents created and maintained by the University of California, San Francisco, Library and Center for Knowledge Management. DIDA is a part of the larger UCSF Industry Documents Library which includes the Truth Tobacco Industry Documents. The archive contains documents about pharmaceutical industry clinical trials, publication of study results, pricing, marketing, relations with physicians and drug company involvement in continuing medical education.

<span class="mw-page-title-main">Sue Desmond-Hellmann</span> American oncologist, academic, and nonprofit administrator

Sue Desmond-Hellmann is an American oncologist and biotechnology leader who served as the Chief Executive Officer of the Bill & Melinda Gates Foundation from 2014–2020. She was previously Chancellor of the University of California, San Francisco (UCSF), the first woman to hold the position, and Arthur and Toni Rembe Rock Distinguished Professor, and before that president of product development at Genentech, where she played a role in the development of the first gene-targeted cancer drugs, Avastin and Herceptin.

The United States Cochrane Center (USCC) was one of the 14 centers on the world that facilitated the work of the Cochrane Collaboration. The USCC was the reference center for all 50 US states and US territories, protectorates, and districts: the District of Columbia, American Samoa, Guam, the Northern Mariana Islands, Puerto Rico, and the US Virgin Islands. The USCC was also the reference Center for the following countries: Antigua and Barbuda, Bahamas, Barbados, Belize, Dominica, Grenada, Guam, Guyana, Jamaica, Japan, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, and Trinidad and Tobago. The USCC discontinued on February 7, 2018.

<span class="mw-page-title-main">Drummond Rennie</span>

Drummond Rennie is an American nephrologist and high altitude physiologist who is a contributing deputy editor of The Journal of the American Medical Association (JAMA) and an adjunct professor of medicine at the University of California, San Francisco.

Conflict of interest in the health care industry occurs when the primary goal of protecting and increasing the health of patients comes into conflict with any other secondary goal, especially personal gain to healthcare professionals, and increasing revenue to a healthcare organization from selling health care products and services. The public and private sectors of the medical-industrial complex have various conflicts of interest which are specific to these entities.

<span class="mw-page-title-main">UCSF Library</span>

The UCSF Library is the library of the University of California, San Francisco. It is one of the world's foremost libraries in the health sciences.

The UCSF School of Medicine is the medical school of the University of California, San Francisco and is located at the base of Mount Sutro on the Parnassus Heights campus in San Francisco, California. Founded in 1864 by Hugh Toland, it is the oldest medical school in California and in the western United States. U.S. News & World Report ranked the school third in research training and second in primary care training; it is the only medical school in the nation to rank among the top three in both categories. Six members of the UCSF faculty have received the Nobel Prize in Physiology or Medicine and five have received the National Medal of Science.

<span class="mw-page-title-main">John C. Greene</span>

John C. Greene was an American dentist and public health administrator. He was a rear admiral in the U.S. Public Health Service Commissioned Corps, and served as the Deputy Surgeon General of the United States under President Carter from 1978 to 1981. He was the Acting Surgeon General from January to May 1981 under Ronald Reagan. He was the highest ranking non-physician public health officer in the history of the U.S. government.

<span class="mw-page-title-main">Kirsten Bibbins-Domingo</span> American epidemiologist and physician

Kirsten Bibbins-Domingo is an American epidemiologist and physician. She is the 17th Editor in Chief of the Journal of the American Medical Association (JAMA) and the JAMA Network. She is Professor of Epidemiology and Biostatistics and the Lee Goldman, MD Endowed Professor of Medicine at University of California, San Francisco. She is a general internist and attending physician at San Francisco General Hospital.

Naomi E. Stotland is an American obstetrician-gynecologist. She is a professor and the associate director of medical student education at UCSF School of Medicine.

Kathleen M. Giacomini is a professor of bioengineering and therapeutic sciences at the University of California, San Francisco. Her work focuses on how genetics affects the efficacy of drugs. She is also the co-Director UCSF-Stanford Center of Excellence in Regulatory Sciences and Innovation for the department of Bioengineering at the University of California, San Francisco.

<span class="mw-page-title-main">Eliseo J. Pérez-Stable</span> Cuban-American physician-scientist

Eliseo J. Pérez-Stable is a Cuban-American physician-scientist. He is the director of the National Institute on Minority Health and Health Disparities.

<span class="mw-page-title-main">Diane Havlir</span> US leader of HIV/AIDS work

Diane Havlir is an American physician who is a Professor of Medicine and Chief of the HIV/AIDS Division at the University of California, San Francisco. Her research considers novel therapeutic strategies to improve the lives of people with HIV and to support public health initiatives in East Africa. She was elected to the National Academy of Medicine in 2019.

<span class="mw-page-title-main">Julia Adler-Milstein</span> Professor of Medicine

Julia Adler-Milstein is a Professor of Medicine and Director of the Center for Clinical Informatics and Improvement Research at the University of California, San Francisco. In 2019, she was named a Member of the National Academy of Medicine.

Rita Fran Redberg is an American cardiologist and the editor-in-chief of JAMA Internal Medicine.

Catherine "Kit" Ann Chesla is an American nurse who is Professor Emeritus and former Thelma Shobe Endowed Chair at the University of California, San Francisco School of Nursing. Her research has considered families and chronic illness.

References

  1. 1 2 3 4 Holmes, D (19 May 2012). "Lisa Bero: Taking the path of most resistance". Lancet. 379 (9829): 1869. doi:10.1016/S0140-6736(12)60797-1. PMID   22608326. S2CID   205966183.
  2. 1 2 3 Lo, Bernard; Field, Marilyn J.; Committee on Conflict of Interest in Medical Research, Education, and Practice, Board on Health Sciences (2009). Conflict of interest in medical research, education, and practice. Washington, D.C.: National Academies Press. ISBN   978-0-309-13188-9.{{cite book}}: CS1 maint: multiple names: authors list (link)
  3. 1 2 Faculty of Pharmacy. "Professor Lisa Bero". University of Sydney. Retrieved 3 November 2014.
  4. 1 2 3 Department of Clinical Pharmacy. "Faculty & Staff". University of California San Francisco. Archived from the original on 28 October 2013. Retrieved 1 December 2013.
  5. 1 2 3 4 5 University of California San Francisco. "Lisa Bero, PhD". UCSF profiles. Retrieved 2 December 2013.
  6. 1 2 3 World Health Organization. "WHO Collaborating Centres Global Database". World Health Organization. Retrieved 2 December 2013.
  7. ↑ "Steering Group and Subgroups". Cochrane Collaboration. Retrieved 9 March 2014.
  8. 1 2 3 Philip R. Lee Institute for Health Policy Studies. "Harold S. Luft Award for Mentoring in Health Services and Health Policy Research". University of California San Francisco. Archived from the original on 8 March 2015. Retrieved 1 December 2013.{{cite web}}: |last= has generic name (help)
  9. ↑ Bero, Lisa (1987). The interaction of opioid and serotonergic systems regulation prolactin secretion in the developing rat (PhD dissertation). Durham, NC: Duke University.
  10. 1 2 3 4 5 Chilingerian, Jon; Kay, Corinne; Institute of Medicine (1997). The lessons and the legacy of the Pew Health Policy Program. Washington, D.C.: National Academy Press. ISBN   978-0-309-05825-4.
  11. ↑ Bero, Lisa (27 July 2008). "Snuff out tobacco sales in S.F. pharmacies". San Francisco Business Times. Retrieved 1 December 2013.
  12. ↑ Glantz, Stanton A.; Slade, J.; Bero, L.A.; Hanauer, P.; Barnes, D.E. (1996). The Cigarette Papers. Berkeley: University of California Press. ISBN   9780520213722.
  13. ↑ Weiner, Jon (1 January 1996). "The Cigarette Papers". Frontline, PBS. Retrieved 1 December 2013.
  14. ↑ Cochrane Effective Practice and Organisation of Care Group. "Newsletters". Cochrane Collaboration. Archived from the original on 15 September 2013. Retrieved 1 December 2013.
  15. ↑ "Advisory Committee on Health Research (ACHR)". List of ACHR members, their nationality and tenure. Pan-American Health Organization. Retrieved 9 March 2014.
  16. 1 2 World Health Organization. "TCC/WHO Collaboration Plan for the Period 2010-2012" (PDF). WHO Ref NoN61/348/165. Cochrane Collaboration. Retrieved 9 March 2014.
  17. ↑ Bero, L.A.; Grilli, R.; Grimshaw, J.M.; Harvey, E.; Oxman, A.D.; Thomson, M.A. (15 August 1998). "Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group". BMJ (Clinical Research Ed.). 317 (7156): 465–8. doi:10.1136/bmj.317.7156.465. PMC   1113716 . PMID   9703533.
  18. ↑ Ober, M.; Shohara, R.; Rennie, D.; Yank, V.; Bero, L.A. (March 2002). "The Criticism Management System for the Cochrane Library". Evaluation & the Health Professions. 25 (1): 98–115. doi:10.1177/0163278702025001007. PMID   11868449. S2CID   1217743.
  19. ↑ University of California San Francisco Magazine. University Publications, University of California, San Francisco, Department of Public Affairs. 1994. p. 6.
  20. ↑ "More about us". US Cochrane Center. Retrieved 9 March 2014.
  21. ↑ "The San Francisco Branch of the US Cochrane Center". UCSF. Retrieved 9 March 2014.
  22. ↑ The San Francisco Division of the Academic Senate. "The 2008-2009 Distinction in Mentoring Award Recipients". University of California San Francisco. Retrieved 1 December 2013.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.